Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
KenChowder's Profile
Displaying 1-50 of 1201 result(s).
CYDY CytoDyn Inc
08/16/2025 2:53:31 AM
Great stuff! If Maraviroc can help (9)
CYDY CytoDyn Inc
08/13/2025 6:03:10 AM
Good post, My. And obviously you ar (14)
CYDY CytoDyn Inc
08/09/2025 2:50:16 AM
My writes: I have read in our paten (21)
CYDY CytoDyn Inc
08/08/2025 9:40:10 AM
Thank you, Respert. We can always c (3)
CYDY CytoDyn Inc
08/08/2025 3:26:35 AM
Study of an aggressive cancer sugge (9)
CYDY CytoDyn Inc
08/07/2025 2:04:48 PM
The last FDA was corrupt and narrow (12)
CYDY CytoDyn Inc
08/07/2025 9:03:31 AM
Yes, a stock that moves 5 or 10 per (1)
CYDY CytoDyn Inc
08/07/2025 6:53:15 AM
Here's another paper that supports (7)
CYDY CytoDyn Inc
08/07/2025 4:29:18 AM
Not sure Mr./Ms. Rug's figures are (6)
CYDY CytoDyn Inc
08/06/2025 3:39:11 AM
Expecting one very soon and please (7)
CYDY CytoDyn Inc
08/02/2025 8:55:17 AM
There was an infamous Mayor of Phil (2)
CYDY CytoDyn Inc
07/23/2025 5:29:34 PM
Sherlock, companies who make tender (6)
CYDY CytoDyn Inc
07/23/2025 3:13:18 AM
MGK wrote: Based on above hypothesi (11)
CYDY CytoDyn Inc
07/22/2025 11:16:35 AM
Another poster corrected me on the (4)
CYDY CytoDyn Inc
07/22/2025 9:15:17 AM
Yes, that Reddit post is worth a re (12)
CYDY CytoDyn Inc
07/21/2025 12:10:16 PM
It might not be a bash, but it is n (5)
CYDY CytoDyn Inc
07/18/2025 4:42:32 PM
Uh oh. RTB. If he is involved, it i (4)
CYDY CytoDyn Inc
07/16/2025 4:50:47 PM
Many thanks for this, Ohm. Very hel (8)
CYDY CytoDyn Inc
07/16/2025 9:37:55 AM
To be honest, to a layperson like m (13)
CYDY CytoDyn Inc
07/16/2025 9:15:42 AM
Good news, Riz. But what is My sayi (2)
CYDY CytoDyn Inc
07/13/2025 10:15:38 AM
I think we had some collaboration w (4)
CYDY CytoDyn Inc
07/13/2025 7:12:54 AM
The study financed by a mysterious (7)
CYDY CytoDyn Inc
07/09/2025 7:57:12 AM
You forgot the antecedent: Are you (23)
CYDY CytoDyn Inc
07/07/2025 5:18:10 PM
Yes, up nearly 12% on the day -- in (6)
CYDY CytoDyn Inc
07/07/2025 12:43:08 PM
Short version: if a company licens (1)
CYDY CytoDyn Inc
07/01/2025 8:38:34 AM
Glad they PRed the CRC survival dat (6)
CYDY CytoDyn Inc
07/01/2025 3:31:25 AM
Yes. Having a DUNS number is benefi (1)
CYDY CytoDyn Inc
06/28/2025 12:09:05 PM
(I think that many here have invest
CYDY CytoDyn Inc
06/28/2025 12:07:02 PM
Sure thing. Misiu, if you think som (4)
CYDY CytoDyn Inc
06/28/2025 10:10:29 AM
There are facts that are good to p (9)
CYDY CytoDyn Inc
06/28/2025 9:42:07 AM
I agree with HH. If a person is act (5)
CYDY CytoDyn Inc
06/26/2025 4:57:47 PM
Well, for starters, we shouldn't n (9)
CYDY CytoDyn Inc
06/26/2025 5:10:12 AM
It will not be to difficult to show (5)
CYDY CytoDyn Inc
06/26/2025 5:04:46 AM
Ganesha, apparently it is an option (19)
CYDY CytoDyn Inc
06/26/2025 2:41:48 AM
The dosage: Five mCRC patients rece (7)
CYDY CytoDyn Inc
06/25/2025 6:06:39 PM
Increased mOs from 7.5 months to 15 (7)
CYDY CytoDyn Inc
06/24/2025 1:59:53 AM
Abstract is released tomorrow at 6: (8)
CYDY CytoDyn Inc
06/19/2025 12:38:54 PM
Thanks, Enjay. I don't know, what d (3)
CYDY CytoDyn Inc
06/19/2025 7:52:50 AM
Mr3, I believe the lowest dosage wa (7)
CYDY CytoDyn Inc
06/19/2025 7:06:24 AM
The CRC ESMO poster will be present (8)
CYDY CytoDyn Inc
06/17/2025 10:58:34 AM
Oh for God's sake. When he says 202 (11)
CYDY CytoDyn Inc
06/17/2025 9:04:51 AM
Don't know what you mean here. Sorr
CYDY CytoDyn Inc
06/17/2025 7:00:02 AM
Thank fortune this is a board for (12)
CYDY CytoDyn Inc
06/16/2025 3:37:51 PM
No, that's exactly what he didn't s (19)
CYDY CytoDyn Inc
06/16/2025 3:14:21 PM
"Market raise"? Dr. Jay has said th (5)
CYDY CytoDyn Inc
06/14/2025 11:39:27 AM
I know that Gilead's drug had no in
CYDY CytoDyn Inc
06/11/2025 12:57:52 PM
Yes, but the results for two other (3)
CYDY CytoDyn Inc
06/11/2025 11:48:40 AM
Results for four Leron trials submi (12)
CYDY CytoDyn Inc
06/11/2025 7:12:52 AM
As Shakespeare would say, "Somethin (5)
CYDY CytoDyn Inc
06/11/2025 3:17:30 AM
The FDA HIV BLA response letter fro (11)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • ParaZero's Advanced Counter Drone Technology: A New Era in Defense
  • Navigating the Booming Security and Vulnerability Management Sector
  • Insights into the Growing Loitering Munition Market Dynamics
  • OneMedNet and Circle CVI Forge Innovative Partnership for Health Data
  • Promising Outcomes from Plus Therapeutics' Clinical Trial for REYOBIQ
  • Successful Collaboration Elevates Revival Gold’s Testing Results
  • Bitdeer Technologies Achieves Record Q2 2025 Financial Growth
  • Allied Properties Announces Key Developments in Urban Projects
  • Transforming Last-Mile Delivery: Serve Robotics' Smart Acquisition
  • Howard Hughes Holdings Announces Annual Meeting and Leadership Changes
  • Talisker Reports High-Grade Gold Assays from Mustang Mine
  • Bitdeer Technologies Group: Q2 2025 Financial Unveiling Insights
  • Enhancements to SUNucate Legislation for Skin Cancer Safety
  • Growth and Trends in the Direct to Chip Liquid Cooling Market
  • Exciting Developments in Coppernico's Sombrero Project Exploration
  • Gray Media Sets New Milestone with 10 Murrow Awards for Excellence
  • Serve Robotics Enhances Last-Mile Delivery with Vayu Acquisition
  • Understanding Age Bias: The Hidden Struggles of Over-50s
  • Howard Hughes Holdings Prepares for Annual Shareholder Meeting
  • CBAK Energy Reveals Q2 & H1 2025 Financial Outcomes
  • American Lithium Secures $9.4 Million in Private Placement Funding
  • Wayne Duso Joins Bitfarms Board to Propel AI and HPC Growth
  • Gambling.com (GAMB) Earnings: A Promising Investment Opportunity
  • Traws Pharma Advances Ratutrelvir Trials for COVID Treatment
  • Cielo Waste Solutions Finalizes Unit Offering with Success
  • Apollo Silver Partners with CDMG to Boost Marketing Outreach
  • Bath & Body Works Unveils Enchanting Disney Villains Collection
  • SRx Health Solutions Moves to Acquire Royal Uranium Assets
  • Cielo Waste Solutions Completes Final Unit Offering Tranche
  • Bitfarms Strengthens Leadership with Wayne Duso on Board
  • BTCS Declares Innovative Bividend in Ethereum for Shareholders
  • BTCS Shares Set to Benefit from Innovative Ethereum Bividend
  • Gray Media Expands Partnerships with Fox Television Network
  • Key Milestones for FibroGen: Acquisition and Future Prospects
  • FibroGen's Strategic Move with AstraZeneca Approved Sale
  • Atlantic International Corp. Gears Up for Gateway Conference
  • Tintina Mines Advances Drilling and Geometallurgical Insights
  • American Lithium Secures Significant Funding Through Placement
  • Global Release of Ruta's Closet: A Holocaust Narrative
  • Unlocking Edge AI Opportunities with Lantronix and Teal Drones
  • Endeavour Mining Expands Leadership with New Director Role
  • Atlantic International Corp. Engages at Gateway Conference
  • Trident's Groundbreaking Venture into Web 3.0 E-Commerce Solutions
  • Modernizing Student Transport: A New Partnership for Safety
  • BioXcel Therapeutics Gains FDA Support for BXCL501 Use
  • CodeMettle Secures $45.2M Contract for U.S. Army Software
  • Bank Mizrahi Tefahot Enhances Share Liquidity with New Program
  • Endeavour Mining's New Director Role Boosts Corporate Governance
  • Bank Mizrahi Tefahot Enhances Share Liquidity with Program
  • SipSource Report Reveals Trends Impacting Wine and Spirits
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site